Skip to Content
Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.
Authors: Lakhani SR,  Jacquemier J,  Sloane JP,  Gusterson BA,  Anderson TJ,  van de Vijver MJ,  Farid LM,  Venter D,  Antoniou A,  Storfer-Isser A,  Smyth E,  Steel CM,  Haites N,  Scott RJ,  Goldgar D,  Neuhausen S,  Daly PA,  Ormiston W,  McManus R,  Scherneck S,  Ponder BA,  Ford D,  Peto J,  Stoppa-Lyonnet D,  Bignon YJ,  Struewing JP,  Spurr NK,  Bishop DT,  Klijn JG,  Devilee P,  Cornelisse CJ,  Lasset C,  Lenoir G,  Barkardottir RB,  Egilsson V,  Hamann U,  Chang-Claude J,  Sobol H,  Weber B,  Stratton MR,  Easton DF
Journal: J Natl Cancer Inst
Date: 1998 Aug 5
Branches: CGB
PubMed ID: 9701363
PMC ID: not available
Abstract: BACKGROUND: We have previously demonstrated that breast cancers associated with inherited BRCA1 and BRCA2 gene mutations differ from each other in their histopathologic appearances and that each of these types differs from breast cancers in patients unselected for family history (i.e., sporadic cancers). We have now conducted a more detailed examination of cytologic and architectural features of these tumors. METHODS: Specimens of tumor tissue (5-microm-thick sections) were examined independently by two pathologists, who were unaware of the case or control subject status, for the presence of cell mitosis, lymphocytic infiltration, continuous pushing margins, and solid sheets of cancer cells; cell nuclei, cell nucleoli, cell necrosis, and cell borders were also evaluated. The resulting data were combined with previously available information on tumor type and tumor grade and further evaluated by multifactorial analysis. All statistical tests are two-sided. RESULTS: Cancers associated with BRCA1 mutations exhibited higher mitotic counts (P = .001), a greater proportion of the tumor with a continuous pushing margin (P<.0001), and more lymphocytic infiltration (P = .002) than sporadic (i.e., control) cancers. Cancers associated with BRCA2 mutations exhibited a higher score for tubule formation (fewer tubules) (P = .0002), a higher proportion of the tumor perimeter with a continuous pushing margin (P<.0001), and a lower mitotic count (P = .003) than control cancers. CONCLUSIONS: Our study has identified key features of the histologic phenotypes of breast cancers in carriers of mutant BRCA1 and BRCA2 genes. This information may improve the classification of breast cancers in individuals with a family history of the disease and may ultimately aid in the clinical management of patients.